|
AMRX | Amneal Pharmaceuticals, Inc. |
|
|
AMRX | Amneal Pharmaceuticals, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ -0.05 |
| Leverage | 103.28% |
| Market Cap | $ 2.4B |
| PE | 51.89 |
| Dividend Yield | 0.00% |
| Profit | $ 46.3m |
| Margin | 1.62% |
Amneal Pharmaceuticals, Inc. develops, licenses, manufactures, markets and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company is headquartered in Bridgewater, New Jersey.